ADCT
Adc Therapeutics Sa
NYSE · Biotechnology
$4.01
+0.10 (+2.56%)
Open$3.97
Previous Close$3.91
Day High$4.20
Day Low$3.93
52W High$4.80
52W Low$1.05
Volume—
Avg Volume805.5K
Market Cap496.75M
P/E Ratio—
EPS$-1.51
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+388.0% upside
Current
$4.01
$4.01
Target
$19.57
$19.57
$11.03
$19.57 avg
$23.80
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 90.32M | 70.64M | 68.24M |
| Net Income | -201,250,748 | -141,670,452 | 9.55M |
| Profit Margin | -222.8% | -211.7% | 14.0% |
| EBITDA | -149,271,914 | -110,917,730 | 13.43M |
| Free Cash Flow | — | — | 5.05M |
| Rev Growth | +27.9% | +27.9% | +14.2% |
| Debt/Equity | 3.72 | 3.72 | 0.70 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |